0.95
+0.0592(+6.57%)
Currency In USD
| Previous Close | 0.89 |
| Open | 0.87 |
| Day High | 0.99 |
| Day Low | 0.87 |
| 52-Week High | 1.59 |
| 52-Week Low | 0.7 |
| Volume | 130,352 |
| Average Volume | 134,104 |
| Market Cap | 52.22M |
| PE | -2.65 |
| EPS | -0.36 |
| Moving Average 50 Days | 0.95 |
| Moving Average 200 Days | 0.98 |
| Change | 0.06 |
If you invested $1000 in Cytosorbents Corporation (CTSO) 10 years ago, it would be worth $87.46 as of December 26, 2024 at a share price of $0.952. Whereas If you bought $1000 worth of Cytosorbents Corporation (CTSO) shares 5 years ago, it would be worth $244.21 as of December 26, 2024 at a share price of $0.952.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CytoSorbents Rights Offering Begins
GlobeNewswire Inc.
Dec 23, 2024 12:00 PM GMT
To Participate, Eligible Stockholders Should Consult Their Broker or Financial Advisor in Advance of the Rights Offering Expiration on January 10, 2025PRINCETON, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO) announ
CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week
GlobeNewswire Inc.
Dec 12, 2024 12:00 PM GMT
PRINCETON, N.J., Dec. 12, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced today that manag
CytoSorbents Announces Rights Offering
GlobeNewswire Inc.
Dec 09, 2024 12:00 PM GMT
Investors Must Hold or Buy CTSO Common Stock by Close of Nasdaq Trading on Friday, December 13, 2024 to ParticipatePRINCETON, N.J., Dec. 09, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threate